Nicolas Gaudenzio, 35, graduated from the University Paul Sabatier in Toulouse, France. Following a 4-year postdoctoral period in the laboratory of Stephen J. Galli, Department of Pathology, University of Stanford (CA USA), he became in 2019 Principal Investigator at Inserm, France. He published first and senior author articles in Nature Immunology, Journal of Clinical Investigations, Journal of Allergy and Clinical Immunology, Annual Review of Immunology and others. He was awarded a French ATIP-Avenir grant and a European Research Council (ERC) Starting grant.
Dr Gaudenzio pursues his research on the role of skin-projecting nociceptors as regulators of immune-driven damage during allergic inflammation at the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Inserm – CNRS – University of Toulouse.
https://www.infinity.inserm.fr/en/research-teams/team-3-n-gaudenzio/
He is now the 2021 laureate of the prestigious ACTERIA Early career Prize in Allergology awarded once every 3 years by the European Federation of Immunological Societies (EFIS).
https://www.acteriaprizes.net/?error=1&display_errorpage=1